Sage Therapeutics, Inc. (SAGE)
After hours:
| Previous close | 12.01 |
| Open | 11.92 |
| Bid | 11.67 x 400 |
| Ask | 11.75 x 100 |
| Day's range | 11.67 - 12.04 |
| 52-week range | 10.92 - 59.99 |
| Volume | |
| Avg. volume | 1,013,650 |
| Market cap | 704.129M |
| Beta (5Y monthly) | 0.91 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -8.39 |
| Earnings date | 05 Aug 2024 - 09 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 21.88 |
Insider Monkey15 Most Depressed States in the US
In this article, we will be taking a look at the 15 most depressed states in the US. If you are not interested in learning about the global and regional trends in the depression treatment market, head straight to the 5 Most Depressed States in the US. Global and Regional Trends in the Depression Treatment […]
Business WireSage Therapeutics to Participate in Upcoming May Investor Conferences
CAMBRIDGE, Mass., May 07, 2024--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will participate in the following upcoming investor conferences in May:
Insider MonkeySage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript
Sage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript April 25, 2024 Sage Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.8 EPS, expectations were $-1.63. Sage Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, […]
